On January 1, 2026, China's state asset regulator — the State-owned Assets Supervision and Administration Commission (SASAC) — officially enacted Order No. 46: Implementation Measures for Accountability in Violations of Operating and Investment Rules by Central Enterprises. The measures explicitly list "selling, purchasing, or using pseudo-innovative or pseudo-domestic products to falsely complete R&D tasks" as an accountable offense under scientific and technological innovation. At the same time, the measures introduce exemption and error-tolerance provisions for qualified R&D activities, technology commercialization, and domestic equipment substitution efforts.
From research institutes to industrial sites, an increasing number of high-end application scenarios in China are placing greater demands on the performance, stability, and technological independence of domestically produced scientific instruments. To meet these demands, enterprises must not only master key core technologies but also build robust R&D systems capable of translating technical achievements into reliable, production-ready products.
Independent R&D and industrialization are precisely the development directions that EXPEC Technology has always upheld.
New Regulations Set Clearer Standards for Technological Innovation
Order No. 46 explicitly includes "selling, purchasing, or using pseudo-innovative or pseudo-domestic products to falsely complete R&D tasks" as an accountable offense, and further strengthens China's accountability mechanism for violations by centrally managed state-owned enterprises.
For the scientific instrument industry, greater scrutiny will now be placed on whether the sources of technology are transparent, whether R&D processes are genuine, and whether innovation outcomes can withstand independent verification. Beyond product performance, core technology ownership, R&D foundations, and the level of industrialization will increasingly serve as key benchmarks for evaluating a company's true capabilities.
Since its founding, EXPEC Technology has maintained a commitment to independent development of core technologies, conducting technical breakthroughs in high-end scientific instruments and applying research outcomes to real-world products. For scientific instrument companies, independent R&D is not simply a breakthrough in a single technology or product — it is a systemic effort spanning core components, complete instrument development, software platforms, application development, and technical services.
After years of sustained investment, EXPEC Technology has progressively built a system encompassing R&D, manufacturing, application, and services, laying the groundwork for technology iteration and product industrialization.
New Regulations Set Clearer Standards for Technological Innovation
Since its establishment in 2015, EXPEC Technology has focused on high-end analytical instruments — particularly mass spectrometry — with an emphasis on core technology development and industrial application.
Spanning mass spectrometry, chromatography, spectroscopy, and physical-chemical analysis, the company has established more than 10 R&D technology platforms, covering fundamental research, product development, engineering validation, and industrial application. All members of the R&D team hold at least a bachelor's degree, with those holding master's or doctoral degrees accounting for more than 95% of the team.
Over the years, EXPEC Technology has actively participated in scientific instrument standardization work, leading or contributing to a total of 59 standards across international, Chinese national, industry, and regional levels. In terms of intellectual property, the company holds 250 authorized patents and 259 registered software copyrights.
The company has been recognized as a National Postdoctoral Research Workstation, the Zhejiang Province Key Enterprise Research Institute for Mass Spectrometry Technology, and the Zhejiang Province Mass Spectrometry Instrument Innovation Center — among other state-level and provincial innovation platforms. It has received China's National Science and Technology Progress Award (First Prize and Second Prize) — the country's highest state honor in science and technology — along with multiple designations as a first-of-its-kind domestic instrument at the national and provincial levels.
In the area of core technology, EXPEC Technology has conducted R&D across key components including ion sources, ion transmission systems, triple quadrupole mass analyzers, electronic control systems, and software operating platforms, advancing the collaborative development of core components, complete instrument systems, and software platforms.
From R&D platform construction and key technology breakthroughs to product development and application validation, EXPEC Technology has progressively formed a comprehensive independent R&D system that provides the technical foundation for the industrialization of high-end scientific instruments.
Proving Product Capability Through Large-Scale Application
For scientific instruments to move from R&D to the market, they must be tested across diverse application scenarios. Whether product performance is stable, whether it can handle complex application requirements, and whether the service system can provide long-term support all directly affect the user experience.
To date, EXPEC Technology's full range of mass spectrometry products has achieved annual sales of over 1,000 units, with products having undergone long-term testing through volume delivery and real-world use.
EXPEC Technology's products are currently deployed at leading Chinese institutions including the Chinese Academy of Sciences, the Chinese Academy of Agricultural Sciences, China's public security system, and top-tier research universities (China's 985/211 institutions), as well as government agencies, research institutes, and industry enterprises — spanning scientific research, testing, and industrial application scenarios.
In the international testing market, multiple leading third-party testing organizations have adopted EXPEC Technology products, building practical experience across a wide range of testing environments.
In 2025, EXPEC Technology successfully won competitive bids in China's large-scale government centralized procurement programs covering ICP-MS, GC-MS, LC-MS/MS, and advanced microwave digestion systems. Across several product categories, EXPEC Technology was the only domestic brand selected — reflecting the growing application base and market competitiveness of Chinese-made high-end scientific instruments in government procurement.
From technology development to volume delivery, and from scientific research to testing and industrial applications, EXPEC Technology drives the realization of R&D outcomes through its products and services — while continuously refining product performance and application solutions through real-world feedback.
For users evaluating whether a domestically produced high-end scientific instrument represents genuine independent innovation, brand name and specification sheets are not enough. Four dimensions matter: whether the sources of core technologies and key components are clearly documented; whether the hardware and software systems have the capacity for continuous iteration; whether product performance can be repeatedly verified in real-world scenarios; and whether the application and service system can sustain stable long-term operation.
Committed to Independent R&D and the Industrialization of Technology
High-end scientific instruments span multiple technical domains, involve long development cycles, and present high barriers to industrialization. They require sustained long-term investment from enterprises in core technology, product engineering, and application services.
EXPEC Technology has built an end-to-end industrial chain — from core components to complete instruments, and from R&D and manufacturing through to application and service. Its products and solutions serve sectors including semiconductors, environmental monitoring, food safety, and life sciences.
Looking ahead, EXPEC Technology will continue to uphold its founding mission: taking on China's national mandates and focusing on the R&D and industrialization of major scientific instruments. The company will deepen efforts in core technology development and product iteration, strengthen its product and service ecosystem, and deliver high-quality scientific instruments that meet the real-world needs of scientific research, testing, and industrial sectors.
EXPEC Technology welcomes industry clients and partners to visit FPI Qingshan Lake Innovation Base — to explore its scientific instrument R&D system and industrialization practices firsthand, and to jointly advance the innovative development of China's domestic scientific instrument industry.
